These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Haug U; Hundt S; Brenner H Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091 [TBL] [Abstract][Full Text] [Related]
4. Development of a Combined Human Transferrin-Hemoglobin Lateral Immunochromatographic Assay for Accurate and Rapid Fecal Occult Blood Test. Ye Y; Deng Y; Mao J; Yan Q; Huang Y; Zhang J; Zheng J; Li Y; Chen W Clin Lab; 2018 May; 64(5):805-813. PubMed ID: 29739056 [TBL] [Abstract][Full Text] [Related]
5. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048 [TBL] [Abstract][Full Text] [Related]
6. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Fletcher RH; Ransohoff DF; Imperiale TF Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313 [No Abstract] [Full Text] [Related]
7. Embedded Immunodetection System for Fecal Occult Blood. Lin KW; Chang YC Biosensors (Basel); 2021 Apr; 11(4):. PubMed ID: 33916834 [TBL] [Abstract][Full Text] [Related]
8. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. Liles EG; Perrin N; Rosales AG; Smith DH; Feldstein AC; Mosen DM; Levin TR BMC Cancer; 2018 May; 18(1):509. PubMed ID: 29720130 [TBL] [Abstract][Full Text] [Related]
9. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers. Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937 [TBL] [Abstract][Full Text] [Related]
10. A Study of Immunochromatographic Fecal Occult Blood Test Methods. Wang S; Wang X; Tang S; Chen Y; Jia J; Chen J; Shen H; Bai B Lab Med; 2019 Apr; 50(2):130-137. PubMed ID: 30169856 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience. Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714 [TBL] [Abstract][Full Text] [Related]
12. [Diverging detection limits of immunochemical tests for occult blood underline the necessity of standardization and quality assurance]. Lüthgens K; Albert S; Brenner H Z Gastroenterol; 2016 Apr; 54(4):299-303. PubMed ID: 27056457 [TBL] [Abstract][Full Text] [Related]
13. Comparison of tests for fecal lactoferrin and fecal occult blood for colorectal diseases: a prospective pilot study. Saitoh O; Kojima K; Kayazawa M; Sugi K; Tanaka S; Nakagawa K; Teranishi T; Matsuse R; Uchida K; Morikawa H; Hirata I; Katsu K Intern Med; 2000 Oct; 39(10):778-82. PubMed ID: 11030199 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia]. Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126 [TBL] [Abstract][Full Text] [Related]
15. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Smith A; Young GP; Cole SR; Bampton P Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938 [TBL] [Abstract][Full Text] [Related]
16. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening. Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346 [TBL] [Abstract][Full Text] [Related]
17. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Fann JC; Chou CK; Lee YC; Wu MS; Chen HH Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099 [TBL] [Abstract][Full Text] [Related]
18. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces. Sieg A; Thoms C; Lüthgens K; John MR; Schmidt-Gayk H Int J Colorectal Dis; 1999 Dec; 14(6):267-71. PubMed ID: 10663892 [TBL] [Abstract][Full Text] [Related]
19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A; Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]